Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Nov;74(3):709–713. doi: 10.1111/j.1476-5381.1981.tb10482.x

Facilitation by clonidine of purine release induced by high KCl from the rabbit pulmonary artery.

T Katsuragi, C Su
PMCID: PMC2071749  PMID: 7296170

Abstract

1 The effect of clonidine on the 3H-purine release evoked by KCl or (-)-adrenaline was assessed in the superfused helical strip of the rabbit pulmonary artery pretreated with [3H]-adenosine. 2 Clonidine (3 x 10(-5) M to 10(-4) M) significantly enhanced the 3H-purine efflux evoked by 50 mM KCl but not by 3 x 10(-6) M) (-)-adrenaline. 3 This facilitatory effect of clonidine on the KCl-induced purine release was unaltered by phentolamine 3 x 10(-6) M. It was absent in arterial segments denervated with 6-hydroxydopamine 30 microgram/ml. 4 A sustained contractile response was evoked by clonidine 3 x 10(-5) M without an increase in the 3H-purine efflux. This was significantly reduced by phentolamine 3 x 10(-6) M, but not by yohimbine 10(-5) M or by denervation with 6-hydroxydopamine. 5 The uptake of [3H]-adenosine into the segments was not inhibited by clonidine 3 x 10(-5) M. 6 It is suggested that the facilitation by clonidine of the KCl-induced purine release is due to prevention of presynaptic autoinhibition of purine release from adrenergic nerves, by an antiadenosine action of the drug.

Full text

PDF
709

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clanachan A. S., Johns A., Paton D. M. Presynaptic inhibitory actions of adenine nucleotides and adenosine on neurotransmission in the rat vas deferens. Neuroscience. 1977;2(4):597–602. doi: 10.1016/0306-4522(77)90056-2. [DOI] [PubMed] [Google Scholar]
  2. Eltze M. Investigations on the mode of action of a new antihypertensive drug, urapidil, in the isolated rat vas deferens. Eur J Pharmacol. 1979 Oct 26;59(1-2):1–9. doi: 10.1016/0014-2999(79)90018-9. [DOI] [PubMed] [Google Scholar]
  3. Fedan J. S., Hogaboom G. K., O'Donnell J. P., Colby J., Westfall D. P. Contribution by purines to the neurogenic response of the vas deferens of the guinea pig. Eur J Pharmacol. 1981 Jan 5;69(1):41–53. doi: 10.1016/0014-2999(81)90600-2. [DOI] [PubMed] [Google Scholar]
  4. Fredholm B. B., Hedqvist P. Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem Pharmacol. 1980 Jun 15;29(12):1635–1643. doi: 10.1016/0006-2952(80)90117-3. [DOI] [PubMed] [Google Scholar]
  5. Haeusler G. Cardiovascular regulation by central adrenergic mechanisms and its alteration by hypotensive drugs. Circ Res. 1975 Jun;36(6 Suppl 1):223–232. doi: 10.1161/01.res.36.6.223. [DOI] [PubMed] [Google Scholar]
  6. Hedqvist P., Fredholm B. B. Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement. Naunyn Schmiedebergs Arch Pharmacol. 1976 Jun;293(3):217–223. doi: 10.1007/BF00507344. [DOI] [PubMed] [Google Scholar]
  7. Hodge R. L., Robinson S. M. The action of clonidine on isolated arterial preparations. Aust J Exp Biol Med Sci. 1972 Aug;50(4):517–526. doi: 10.1038/icb.1972.44. [DOI] [PubMed] [Google Scholar]
  8. Katsuragi T., Su C. Purine release from vascular adrenergic nerves by high potassium and a calcium ionophore, A-23187. J Pharmacol Exp Ther. 1980 Dec;215(3):685–690. [PubMed] [Google Scholar]
  9. Langer S. Z. Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol. 1977 Aug;60(4):481–497. doi: 10.1111/j.1476-5381.1977.tb07526.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ress R. J., Field F. P., Lockley O. E., Fregly M. J. Effect of clonidine on the contractile responsiveness of aortic smooth muscle to norepinephrine. Pharmacology. 1979;18(3):149–154. doi: 10.1159/000137244. [DOI] [PubMed] [Google Scholar]
  11. Salt P. J. Inhibition of noradrenaline uptake 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. Eur J Pharmacol. 1972 Dec;20(3):329–340. doi: 10.1016/0014-2999(72)90194-x. [DOI] [PubMed] [Google Scholar]
  12. Starke K., Altmann K. P. Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional -receptors. Neuropharmacology. 1973 Apr;12(4):339–347. doi: 10.1016/0028-3908(73)90093-2. [DOI] [PubMed] [Google Scholar]
  13. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1–124. doi: 10.1007/BFb0050157. [DOI] [PubMed] [Google Scholar]
  14. Stone T. W., Taylor D. A. Antagonism by clonidine of neuronal depressant responses to adenosine, adenosine-5'-monophosphate and adenosine triphosphate. Br J Pharmacol. 1978 Nov;64(3):369–374. doi: 10.1111/j.1476-5381.1978.tb08659.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stone T. W., Taylor D. A. Clonidine as an adenosine antagonist. J Pharm Pharmacol. 1978 Dec;30(12):792–793. doi: 10.1111/j.2042-7158.1978.tb13395.x. [DOI] [PubMed] [Google Scholar]
  16. Su C. Neurogenic release of purine compounds in blood vessels. J Pharmacol Exp Ther. 1975 Oct;195(1):159–166. [PubMed] [Google Scholar]
  17. Su C. Purinergic inhibition of adrenergic transmission in rabbit blood vessels. J Pharmacol Exp Ther. 1978 Feb;204(2):351–361. [PubMed] [Google Scholar]
  18. Verhaeghe R. H., Vanhoutte P. M., Shepherd J. T. Inhibition of sympathetic neurotransmission in canine blood vessels by adenosine and adenine nucleotides. Circ Res. 1977 Feb;40(2):208–215. doi: 10.1161/01.res.40.2.208. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES